EUVIMEDEUVIMED entdecken
Open Access

Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Predicting Complete Pathological Response in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy

Mustafa Karaca iD, Ece Salim, Mustafa Serkan Alemdar iD, Özge Deniz Karaca iD, Mustafa Özgür Arıcı iD

Medical Science Monitor · 2024

DOI: 10.12659/msm.943750 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Science Monitor, 2024. Verfasst von Mustafa Karaca und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Akdeniz University Faculty of Medicine, Antalya, Turkey. Hauptthemen laut MEDLINE: Neoadjuvant Therapy, Rectal Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Pathologic response after neoadjuvant therapy has been shown to improve outcomes in rectal cancer. Inflammatory markers, including neutrophil-to-lymphocyte ratio (NLR), have been studied to predict pathologic response and survival. This study aimed to evaluate the association between NLR and pathological response as well as outcome in patients with rectal cancer who underwent neoadjuvant chemoradiotherapy (nCRT). MATERIAL AND METHODS We retrospectively analyzed 187 patients with rectal cancer treated with nCRT followed by surgery between 2016 and 2020. The NLR was calculated using archival complete blood count records. Postoperative pathology reports were recorded. The NLR cut-off was determined by receiver operating characteristic curve. Kaplan-Meier survival curves and univariate and multivariate Cox regression analyses were used to analyze the relationship between NLR and clinicopathologic data to predict survival and prognosis. RESULTS An NLR >3.63 at diagnosis was the optimal cut-off value for predicting progression. Near-complete response rates were higher in patients with NLR 3.63 (18%) (P=0.035). The NLR 3.63 group (63.6% vs 40.1%, respectively; P=0.007). The NLR 3.63 group (72.3% vs 63.1%, respectively), but the difference was not statistically significant (P=0.077). CONCLUSIONS Our study showed a higher near-complete response rate in rectal cancer patients with NLR

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoadjuvant TherapyRectal NeoplasmsHumansPrognosisNeutrophilsRetrospective StudiesChemoradiotherapyLymphocytes

Autor:innen und Institutionen

  • Department of Medical Oncology, Akdeniz University Faculty of Medicine, Antalya, Turkey.
  • Department of Internal Medicine, Antalya Training and Research Hospital, Antalya, Turkey.
  • Department of Medical Oncology, Antalya Training and Research Hospital, Antalya, Turkey.

ORCID-Profile: Mustafa Karaca, Mustafa Serkan Alemdar, Özge Deniz Karaca, Mustafa Özgür Arıcı

Zitieren

APA

Karaca, M., Salim, E., Alemdar, M. S., Deniz Karaca, Ö., & Arıcı, M. Ö. (2024). Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Predicting Complete Pathological Response in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy. Medical Science Monitor. https://doi.org/10.12659/msm.943750

Vancouver

Karaca M, Salim E, Alemdar MS, Deniz Karaca Ö, Arıcı MÖ. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Predicting Complete Pathological Response in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy. Medical Science Monitor. 2024. doi:10.12659/msm.943750

BibTeX
@article{Karaca2024,
  author = {Karaca, Mustafa and Salim, Ece and Alemdar, Mustafa Serkan and Deniz Karaca, Özge and Arıcı, Mustafa Özgür},
  title = {Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Predicting Complete Pathological Response in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy},
  journal = {Medical Science Monitor},
  year = {2024},
  doi = {10.12659/msm.943750}
}
Kostenlos starten →